Ocular Therapeutix Inc
OCUL
Market Cap$908.24M
Close$
$10.44
77.8% upside
Current Fair Value
77.8% upsideUndervalued by 77.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $908.24 Million |
|---|---|
| Enterprise Value | $795.83 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.94 |
| Beta | 1.94 |
| Outstanding Shares | 154,726,404 |
| Avg 30 Day Volume | 2,871,120 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.25 |
|---|---|
| PEG | -12.78 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 13.62 |
| Enterprise Value to EBIT | -9.66 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Ocular Therapeutix Inc
CEO: Antony Mattessich